The cost of diagnosing Type2 diabetes mellitus by clinical opportunistic screening in general practice

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages 863-868

  Pereira Gray, D J ^a   Evans, P H ^a   Wright, C ^a   Langley, P ^a  

^a St Leonard's Research Practice   (United Kingdom)

Author keywords

Cost; Diagnosis; General practice; Screening; Type2 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; SCREENING; UNITED KINGDOM; COHORT ANALYSIS; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; GLUCOSE TOLERANCE TEST; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; PATIENT REFERRAL;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTICE; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; REFERRAL AND CONSULTATION;

EID: 84862690169     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03607.x     Document Type: Article

References (30)

1. Harris MI, Klein R, Welborn TA, Knuiman MA. Onset of NIDDM occurs at least 4-7years before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
2. NHS Information Centre for Health and Social Care. Prevalence: Quality and Outcomes Framework (QOF) for April 2009-March 2010, England: Numbers on QOF disease registers and raw prevalence rates, England. Available at: Last accessed 9 August 2011.
3. Evans PH, Langley P, Pereira Gray D. Diagnosing type2 diabetes before patients complain of diabetic symptoms - clinical opportunistic screening in a single general practice. Fam Pract 2008; 25: 376-381.
4. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK et al. for the Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44: 1094-1101.
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. for the Finnish Diabetes Prevention Study Group. Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
6. Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M et al. for the Writing Group, on behalf of the IMAGE Study Group. A European evidence-based guideline for the prevention of Type2 diabetes. Horm Metab Res 2010; 42: S3-S36.
7. Holt TA, Stables D, Hippisley-Cox J, O'Hanlon, Majeed A. Identifying undiagnosed diabetes: cross-sectional survey of 3.6million patients' electronic records. Br J Gen Pract 2008; 58: 192-196.
8. Hippisley-Cox J, Vinogradova Y. Trends in Consultation Rates in General Practice 1995/1996 to 2008/2009: Analysis of the QRESEARCH Database. Final Report to the NHS Information Centre and Department of Health. London: QRESEARCH and The Health and Social Care Information Centre, 2009.
9. Greaves C, Stead JW, Hattersley A, Ewings P, Brown P, Evans PH. A simple pragmatic method for detecting new cases of type2 diabetes and impaired fasting glycaemia in primary care. Fam Pract 2004; 21: 57-62.
10. O'Connor PJ, Rush WA, Cherney LM, Pronk NP. Screening for diabetes in high risk patients: cost, yield and acceptability. Eff Clin Pract 2001; 4: 271-277.
11. Dalsgaard EM, Christensen JO, Skriver MV, Borch-Johnsen K, Lauritzen T, Sandbaek A. Comparison of different stepwise screening strategies for type2 diabetes: finding from Danish general practice, Addition-DK. Prim Care Diabetes 2010; 4: 223-229.
12. WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva: World Health Organization, 1999.
13. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E et al. Screening for type2 diabetes: literature review and economic modelling. Health Technol Assess 2007; 11: 1-146.
14. Woolthius EPK, de Grauw WJC, van Gerwen WHE, van den Hoogen HJM, van de Lisdonk EH, Metsemakers JFM et al. Yield of opportunistic targeted screening for type2 diabetes in primary care. The Diabscreen Study. Ann Fam Med 2009; 7: 422-430.
15. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. Geneva: World Health Organization, 2011.
16. Goyder E, Wild S, Fischbacher C, Carlisle J, Peters J. Evaluating the impact of a national pilot screening programme for type2 diabetes in deprived areas of England. Fam Pract 2008; 25: 370-375.
17. Graffy J, Grant J, Williams K, Cohn S, Macbay S, Griffin S et al. More than measurement: practice team experiences of screening for type2 diabetes. Fam Pract 2010; 27: 386-394.
18. Clover B, Gainsbury S, Clews G. Acute sector. Huge A&E attendance gaps revealed. Health Serv J 2010; 120(6209): 4-5.
19. Glumer C, Yuyun, Griffin S Farewell D, Spiegelhalter D, Kinmonth AL et al. What determines the cost-effectiveness of diabetes screening? Diabetologia 2006; 49: 1536-1544.
20. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT et al. Different strategies for screening and prevention of type2 diabetes in adults: cost-effectiveness analysis. Br Med J 2008; 336: 1180-1185.
21. Holman N, Forouhi NG, Goyder E, Wild SH. The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 2011; 28: 575-582.
22. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004; 27: 9-12.
23. Pereira Gray D, Steele R, Sweeney K, Evans P. Generalists in medicine: general practice is medicine with a human face. Br Med J 1994; 308: 486-487.
24. Roland M, Sibbald B, McDonald R. Care closer to home: moving care. Health Serv J 2007; 117: S6-S8.
25. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type2 diabetes in England and Wales: prospective derivation and validation of QDScore. Br Med J 2009; 338: b880.
26. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
27. Pereira Gray DJ. The key to personal care. J R Coll Gen Pract 1979; 29: 666-678.
28. Roland M, Mayor V, Morris R. Factors associated with achieving continuity of care in general practice. J R Coll Gen Pract 1986; 36: 102-104.
29. Drivsholm T, Olivarius NF. General practitioners may diagnose type2 diabetes at an early disease stage in patients they know well. Fam Pract 2006; 23: 192-197.
30. Liu Q, Wang B, Kong Y, Cheng KK. China's primary healthcare reform. Lancet 2011; 377: 2064-2066.